Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.

Dika E, Veronesi G, Altimari A, Riefolo M, Ravaioli GM, Piraccini BM, Lambertini M, Campione E, Gruppioni E, Fiorentino M, Melotti B, Ferracin M, Patrizi A.

Am J Clin Pathol. 2020 Feb 4. pii: aqz209. doi: 10.1093/ajcp/aqz209. [Epub ahead of print]

PMID:
32017841
2.

Restoring Tactile sensations via neural interfaces for real-time force-and-slippage closed-loop control of bionic hands.

Zollo L, Di Pino G, Ciancio AL, Ranieri F, Cordella F, Gentile C, Noce E, Romeo RA, Bellingegni AD, Vadalà G, Miccinilli S, Mioli A, Diaz-Balzani L, Bravi M, Hoffmann KP, Schneider A, Denaro L, Davalli A, Gruppioni E, Sacchetti R, Castellano S, Di Lazzaro V, Sterzi S, Denaro V, Guglielmelli E.

Sci Robot. 2019 May 21;4(27). pii: eaau9924. doi: 10.1126/scirobotics.aau9924. Epub 2019 Feb 20.

3.

Clinical significance of ROS1 5' deletions in non-small cell lung cancer.

Capizzi E, Dall'Olio FG, Gruppioni E, Sperandi F, Altimari A, Giunchi F, Fiorentino M, Ardizzoni A.

Lung Cancer. 2019 Sep;135:88-91. doi: 10.1016/j.lungcan.2019.07.017. Epub 2019 Jul 17.

PMID:
31447007
4.

Simultaneous sEMG Classification of Hand/Wrist Gestures and Forces.

Leone F, Gentile C, Ciancio AL, Gruppioni E, Davalli A, Sacchetti R, Guglielmelli E, Zollo L.

Front Neurorobot. 2019 Jun 19;13:42. doi: 10.3389/fnbot.2019.00042. eCollection 2019.

5.

BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma.

Repaci A, Vicennati V, Paccapelo A, Cavicchi O, Salituro N, Monari F, de Biase D, Tallini G, Altimari A, Gruppioni E, Fiorentino M, Pagotto U.

Int J Endocrinol. 2019 Apr 7;2019:3081497. doi: 10.1155/2019/3081497. eCollection 2019.

6.

Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib.

Nannini M, Tarantino G, Indio V, Ravegnini G, Astolfi A, Urbini M, De Leo A, Santini D, Ceccarelli C, Gruppioni E, Altimari A, Castellucci P, Fanti S, Di Scioscio V, Saponara M, Gatto L, Pession A, Martelli PL, Casadio R, Pantaleo MA.

Sci Rep. 2019 Feb 18;9(1):2172. doi: 10.1038/s41598-018-38028-x.

7.

Artificial Sphincters to Manage Urinary Incontinence: A Review.

Marziale L, Lucarini G, Mazzocchi T, Gruppioni E, Castellano S, Davalli A, Sacchetti R, Pistolesi D, Ricotti L, Menciassi A.

Artif Organs. 2018 Sep;42(9):E215-E233. doi: 10.1111/aor.13164. Epub 2018 Aug 3. Review.

PMID:
30074617
8.

Sockets for Limb Prostheses: A Review of Existing Technologies and Open Challenges.

Paterno L, Ibrahimi M, Gruppioni E, Menciassi A, Ricotti L.

IEEE Trans Biomed Eng. 2018 Sep;65(9):1996-2010. doi: 10.1109/TBME.2017.2775100. Epub 2018 Jan 23.

PMID:
29993506
9.

The S-Finger: A Synergetic Externally Powered Digit With Tactile Sensing and Feedback.

Imbinto I, Montagnani F, Bacchereti M, Cipriani C, Davalli A, Sacchetti R, Gruppioni E, Castellano S, Controzzi M.

IEEE Trans Neural Syst Rehabil Eng. 2018 Jun;26(6):1264-1271. doi: 10.1109/TNSRE.2018.2829183.

PMID:
29877851
10.

Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report.

De Leo A, Nannini M, Dondi G, Santini D, Urbini M, Gruppioni E, De Iaco P, Perrone AM, Pantaleo MA.

BMC Cancer. 2018 Mar 16;18(1):301. doi: 10.1186/s12885-018-4204-1.

11.

Characterization of malignant gastrointestinal stromal tumors-a single center experience.

Mandrioli M, Mastrangelo L, Masetti M, Zanini N, Lega S, Nannini M, Gruppioni E, Altimari A, Dei Tos AP, Fabbri C, Jovine E.

J Gastrointest Oncol. 2017 Dec;8(6):1037-1045. doi: 10.21037/jgo.2017.10.09.

12.

NLR, MLP, SVM, and LDA: a comparative analysis on EMG data from people with trans-radial amputation.

Dellacasa Bellingegni A, Gruppioni E, Colazzo G, Davalli A, Sacchetti R, Guglielmelli E, Zollo L.

J Neuroeng Rehabil. 2017 Aug 14;14(1):82. doi: 10.1186/s12984-017-0290-6.

13.

Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody.

Adua D, Di Fabio F, Ercolani G, Fiorentino M, Gruppioni E, Altimari A, Rojas Limpe FL, Normanno N, Pinna AD, Pinto C.

Mol Clin Oncol. 2017 Jul;7(1):113-120. doi: 10.3892/mco.2017.1270. Epub 2017 May 23.

14.

A Prosthetic Hand Body Area Controller Based on Efficient Pattern Recognition Control Strategies.

Benatti S, Milosevic B, Farella E, Gruppioni E, Benini L.

Sensors (Basel). 2017 Apr 15;17(4). pii: E869. doi: 10.3390/s17040869.

15.

Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST.

Pantaleo MA, Urbini M, Indio V, Ravegnini G, Nannini M, De Luca M, Tarantino G, Angelini S, Gronchi A, Vincenzi B, Grignani G, Colombo C, Fumagalli E, Gatto L, Saponara M, Ianni M, Paterini P, Santini D, Pirini MG, Ceccarelli C, Altimari A, Gruppioni E, Renne SL, Collini P, Stacchiotti S, Brandi G, Casali PG, Pinna AD, Astolfi A, Biasco G.

Mol Cancer Res. 2017 May;15(5):553-562. doi: 10.1158/1541-7786.MCR-16-0376. Epub 2017 Jan 27.

16.

Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.

Fiorentino M, Gruppioni E, Massari F, Giunchi F, Altimari A, Ciccarese C, Bimbatti D, Scarpa A, Iacovelli R, Porta C, Virinder S, Tortora G, Artibani W, Schiavina R, Ardizzoni A, Brunelli M, Knuutila S, Martignoni G.

Oncotarget. 2017 Jan 31;8(5):7328-7335. doi: 10.18632/oncotarget.12551.

17.

Orbital meningeal melanocytoma: Histological, immunohistochemical and molecular characterization of a case and review of the literature.

Palicelli A, Disanto MG, Panzarasa G, Veggiani C, Galizia G, Dal Cin S, Gruppioni E, Boldorini R.

Pathol Res Pract. 2016 Oct;212(10):946-953. doi: 10.1016/j.prp.2016.07.009. Epub 2016 Jul 25. Review.

PMID:
27499153
18.

Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors.

Saponara M, Gatto L, Di Nunno V, Tabacchi E, Fanti S, Di Scioscio V, Nannini M, Gruppioni E, Altimari A, Fiorentino M, Santini D, Ceccarelli C, Zompatori M, Biasco G, Pantaleo MA.

Anticancer Drugs. 2016 Apr;27(4):353-63. doi: 10.1097/CAD.0000000000000331.

PMID:
26720290
19.

The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report.

Tamè M, Calvanese C, Cucchetti A, Gruppioni E, Colecchia A, Bazzoli F.

J Gastrointestin Liver Dis. 2015 Sep;24(3):387-9. doi: 10.15403/jgld.2014.1121.243.gpp.

20.

Virologic and genetic evaluation of vemurafenib-induced skin cancers.

Dika E, Patrizi A, Altimari A, Fiorentino M, La Placa M, Gruppioni E, Venturoli S, Vaccari S, Melotti B, Piraccini BM, Fanti PA.

Cutan Ocul Toxicol. 2015;34(3):251-3. doi: 10.3109/15569527.2014.949345. Epub 2014 Sep 8.

PMID:
25198405
21.

Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease.

Malvi D, Vasuri F, Mattioli B, Gruppioni E, Fiorentino M, Gionchetti P, Grigioni WF, Poggioli G, D'Errico-Grigioni A.

Pathology. 2014 Aug;46(5):439-43. doi: 10.1097/PAT.0000000000000123.

PMID:
24977730
22.

Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Vasuri F, Malvi D, Gruppioni E, Grigioni WF, D'Errico-Grigioni A.

World J Gastroenterol. 2014 Mar 21;20(11):2810-24. doi: 10.3748/wjg.v20.i11.2810. Review.

23.

Learning from errors: response to gefitinib in kidney urothelial carcinoma with EGFR mutations.

Fiorentino M, Giunchi F, Altimari A, Di Tullio P, Gruppioni E, Martorana G, Pinto C.

Oncologist. 2014 Apr;19(4):430. doi: 10.1634/theoncologist.2013-0346. Epub 2014 Mar 20. No abstract available.

24.

Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells.

Storci G, Bertoni S, De Carolis S, Papi A, Nati M, Ceccarelli C, Pirazzini C, Garagnani P, Ferrarini A, Buson G, Delledonne M, Fiorentino M, Capizzi E, Gruppioni E, Taffurelli M, Santini D, Franceschi C, Bandini G, Bonifazi F, Bonafé M.

Am J Pathol. 2013 Nov;183(5):1688-1697. doi: 10.1016/j.ajpath.2013.07.020. Epub 2013 Sep 12.

25.

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.

Altimari A, de Biase D, De Maglio G, Gruppioni E, Capizzi E, Degiovanni A, D'Errico A, Pession A, Pizzolitto S, Fiorentino M, Tallini G.

Onco Targets Ther. 2013 Aug 5;6:1057-64. doi: 10.2147/OTT.S42369. eCollection 2013.

26.

KIT, NRAS, and BRAF mutations in nail apparatus melanoma.

Dika E, Altimari A, Patrizi A, Gruppioni E, Fiorentino M, Piraccini BM, Misciali C, Barisani A, Fanti PA.

Pigment Cell Melanoma Res. 2013 Sep;26(5):758-60. doi: 10.1111/pcmr.12123. Epub 2013 Jun 20. No abstract available.

PMID:
23782496
27.

The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: a retrospective study.

Vasuri F, Morelli MC, Gruppioni E, Fiorentino M, Ercolani G, Cescon M, Pinna AD, Grigioni WF, D'Errico-Grigioni A.

Dig Liver Dis. 2013 Jun;45(6):505-9. doi: 10.1016/j.dld.2012.11.015. Epub 2013 Jan 12.

PMID:
23317815
28.

A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.

Guarnieri V, Baorda F, Battista C, Bisceglia M, Balsamo T, Gruppioni E, Fiorentino M, Muscarella LA, Coco M, Barbano R, Corbetta S, Spada A, Cole DE, Canaff L, Hendy GN, Carella M, Scillitani A.

Endocrine. 2012 Feb;41(1):152-5. doi: 10.1007/s12020-011-9558-y. Epub 2011 Nov 18. No abstract available.

PMID:
22095489
29.
30.

Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples.

Gruppioni E, Vasuri F, Fiorentino M, Capizzi E, Altimari A, Pirini MG, Grazi GL, Malvi D, Grigioni WF, D'Errico-Grigioni A.

Diagn Mol Pathol. 2009 Dec;18(4):232-8. doi: 10.1097/PDM.0b013e3181916e31.

PMID:
19861893
31.

Fine detection of grasp force and posture by amputees via surface electromyography.

Castellini C, Gruppioni E, Davalli A, Sandini G.

J Physiol Paris. 2009 Sep-Dec;103(3-5):255-62. doi: 10.1016/j.jphysparis.2009.08.008. Epub 2009 Aug 7.

PMID:
19665563
32.

Acute cellular rejection monitoring after intestinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings.

Lauro A, Altimari A, Di Simone M, Dazzi A, Cescon M, Zanfi C, Miklosova Z, Corti B, Gruppioni E, D'Errico A, Cautero N, Giustozzi G, Ansaloni L, Ramacciato G, Gruttadauria S, Gruttadauria G, Pinna AD.

Transplant Proc. 2008 Jun;40(5):1575-6. doi: 10.1016/j.transproceed.2008.03.153.

PMID:
18589154
33.

Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance.

Altimari A, Gruppioni E, Capizzi E, Bagni A, Corti B, Fiorentino M, Lazzarotto T, Lauro A, Pinna AD, Ridolfi L, Grigioni WF, D'errico-Grigioni A.

Transplantation. 2008 Jun 27;85(12):1778-83. doi: 10.1097/TP.0b013e318177dfe4.

PMID:
18580471
34.

Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry.

Capizzi E, Gruppioni E, Grigioni AD, Gabusi E, Grassigli A, Grigioni WF, Fiorentino M.

Diagn Mol Pathol. 2008 Dec;17(4):220-6. doi: 10.1097/PDM.0b013e318161f993.

PMID:
18382352
35.

Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.

D'Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF.

Liver Transpl. 2008 Mar;14(3):313-20. doi: 10.1002/lt.21375.

36.

Two years' experience of acute rejection monitoring of intestinal transplant recipients by real-time PCR assessment of granzyme B and perforin up-regulation: considerations on diagnostic accuracy.

Corti B, Altimari A, Gabusi E, Pinna AD, Gruppioni E, Lauro A, Pirini MG, Fiorentino M, Ridolfi L, Grigioni WF, Grigioni AD.

Transplant Proc. 2006 Jul-Aug;38(6):1726-7.

PMID:
16908262
37.

[The pathologist and transplant safety: the histologic control].

Altimari A, Gruppioni E, Gabusi E, Benedettini E, Fiorentino M, Corti B, Pirini MG, Grigioni WF, D'Errico Grigioni A.

Pathologica. 2005 Aug;97(4):196. Italian. No abstract available.

PMID:
16440657
38.

Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients.

Corti B, Altimari A, Gabusi E, Pinna AD, Lauro A, Morselli-Labate AM, Gruppioni E, Pirini MG, Fiorentino M, Ridolfi L, Grigioni WF, D'Errico-Grigioni A.

Transplant Proc. 2005 Dec;37(10):4467-71.

PMID:
16387147
39.

Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections.

Gruppioni E, Corti B, Altimari A, Gabusi E, Panza E, Grazi GL, Pinna AD, De Ruvo N, Fiorentino M, Grigioni WF, Grigioni AD.

Diagn Mol Pathol. 2005 Sep;14(3):170-6.

PMID:
16106199
40.

Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells.

Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C, Colombo MP, Versura P, D'Errico-Grigioni A, Ferri E, Baccarani M, Lemoli RM.

Stem Cells. 2006 Feb;24(2):454-61. Epub 2005 Aug 11.

41.

Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation.

Altimari A, Gruppioni E, Fiorentino M, Petraroli R, Pinna AD, Petropulacos K, Ridolfi L, Costa AN, Grigioni WF, Grigioni AD.

Diagn Mol Pathol. 2005 Mar;14(1):34-8.

PMID:
15714062
42.

Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation.

Fiorentino M, Altimari A, Ravaioli M, Gruppioni E, Gabusi E, Corti B, Vivarelli M, Bringuier PP, Scoazec JY, Grigioni WF, D'Errico-Grigioni A.

Clin Cancer Res. 2004 Mar 1;10(5):1789-95.

43.

[Space-occupying (malignant) lesions of the liver].

D'Errico A, Fiorentino M, Corti B, Altimari A, Gabusi E, Gruppioni E, Pirini MG, Grigioni WF.

Pathologica. 2003 Oct;95(5):253-4. Italian. No abstract available.

PMID:
14989003
44.

Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings.

D'Errico A, Grassigli A, Gruppioni E, Fiorentino M, Corti B, Gabusi E, Morselli-Labate AM, Grigioni WF.

Surgery. 2004 Mar;135(3):248-54; discussion 255-7, 357.

PMID:
14976473
45.

Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation.

D'Errico A, Corti B, Pinna AD, Altimari A, Gruppioni E, Gabusi E, Fiorentino M, Bagni A, Grigioni WF.

Transplant Proc. 2003 Dec;35(8):3061-5.

PMID:
14697980
46.

Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.

Dall'Olio F, Chiricolo M, D'Errico A, Gruppioni E, Altimari A, Fiorentino M, Grigioni WF.

Glycobiology. 2004 Jan;14(1):39-49. Epub 2003 Sep 26.

PMID:
14514712
47.

Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours.

Altimari A, Fiorentino M, Gabusi E, Gruppioni E, Corti B, D'Errico A, Grigioni WF.

Dig Liver Dis. 2003 May;35(5):332-8.

PMID:
12846405

Supplemental Content

Loading ...
Support Center